bisbenzimidazole has been researched along with Glioblastoma in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogush, T | 1 |
| Smirnova, G | 1 |
| Shubina, I | 1 |
| Syrkin, A | 1 |
| Robert, J | 1 |
1 other study available for bisbenzimidazole and Glioblastoma
| Article | Year |
|---|---|
Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines.
Topics: Animals; Binding Sites; Bisbenzimidazole; Carcinoma; Cell Division; Cyanoacrylates; Daunorubicin; DN | 1995 |